COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (Nasdaq: CLGN), a leader in regenerative and aesthetics medicine, has announced its upcoming financial report and conference call for the second quarter of 2024. The company, known for its innovative non-animal-derived collagen technologies, will release its financial statements on Tuesday, August 20, 2024, before U.S. markets open.
A conference call and webcast are scheduled for 10:00 a.m. EDT on the same day. Investors can participate using various dial-in numbers based on their location. A live webcast will also be available in listen-only mode. To streamline the process, CollPlant offers a Call me™ feature for easy access. Investors can submit questions in advance by emailing Dan Ferry at LifeSci Advisors
CollPlant Biotechnologies (Nasdaq: CLGN), leader nella medicina rigenerativa e estetica, ha annunciato il suo prossimo rapporto finanziario e la conferenza telefonica per il secondo trimestre del 2024. L'azienda, conosciuta per le sue innovative tecnologie di collagene non derivato da animali, pubblicherà i bilanci finanziari il martedì 20 agosto 2024, prima dell'apertura dei mercati statunitensi.
Una conferenza telefonica e un webcast sono programmati per le 10:00 EDT dello stesso giorno. Gli investitori possono partecipare utilizzando vari numeri di accesso a seconda della loro posizione. Sarà disponibile anche un webcast dal vivo in modalità ascolto solo. Per semplificare il processo, CollPlant offre una funzione Call me™ per un accesso facile. Gli investitori possono inviare domande in anticipo via email a Dan Ferry di LifeSci Advisors.
CollPlant Biotechnologies (Nasdaq: CLGN), líder en medicina regenerativa y estética, ha anunciado su próximo informe financiero y llamada de conferencia para el segundo trimestre de 2024. La empresa, conocida por sus innovadoras tecnologías de colágeno no derivadas de animales, publicará sus estados financieros el martes 20 de agosto de 2024, antes de la apertura de los mercados en EE.UU.
Una llamada de conferencia y un webcast están programados para las 10:00 a.m. EDT del mismo día. Los inversores pueden participar utilizando varios números de acceso según su ubicación. También estará disponible un webcast en vivo en modo solo escucha. Para agilizar el proceso, CollPlant ofrece una función de Call me™ para un acceso fácil. Los inversores pueden enviar preguntas por adelantado enviando un correo electrónico a Dan Ferry de LifeSci Advisors.
CollPlant Biotechnologies (Nasdaq: CLGN)는 재생 의학 및 미용 의학 분야의 선두주자로서 2024년 2분기 재무 보고서와 컨퍼런스 전화를 발표한다고 발표했습니다. 동물에서 유래하지 않은 혁신적인 콜라겐 기술로 잘 알려진 이 회사는 2024년 8월 20일 화요일에 미국 시장 개장 전에 재무 제표를 발표할 예정입니다.
동일한 날 오전 10시 EDT에 컨퍼런스 전화와 웹캐스트가 예정되어 있습니다. 투자자들은 위치에 따라 다양한 전화번호를 이용해 참여할 수 있습니다. 오직 청취 전용 모드로 실시간 웹캐스트도 제공됩니다. 프로세스를 간소화하기 위해, CollPlant는 쉽게 접근할 수 있는 Call me™ 기능을 제공합니다. 투자자들은 LifeSci Advisors의 Dan Ferry에게 이메일을 통해 사전에 질문을 제출할 수 있습니다.
CollPlant Biotechnologies (Nasdaq: CLGN), leader en médecine régénérative et esthétique, a annoncé son prochain rapport financier et la conférence téléphonique pour le deuxième trimestre de 2024. Connue pour ses technologies de collagène innovantes sans origine animale, la société publiera ses états financiers le mardi 20 août 2024, avant l'ouverture des marchés américains.
Une conférence téléphonique et un webcast sont prévus pour 10h00 EDT le même jour. Les investisseurs peuvent participer en utilisant divers numéros d'accès selon leur localisation. Un webcast en direct sera également disponible en mode écoute seule. Pour faciliter le processus, CollPlant propose une fonction Call me™ pour un accès facile. Les investisseurs peuvent soumettre des questions à l'avance par e-mail à Dan Ferry de LifeSci Advisors.
CollPlant Biotechnologies (Nasdaq: CLGN), ein führendes Unternehmen in der regenerativen Medizin und ästhetischen Medizin, hat seinen bevorstehenden Finanzbericht und die Telefonkonferenz für das zweite Quartal 2024 angekündigt. Das Unternehmen, bekannt für seine innovativen, nicht tierischen Kollagentechnologien, wird seine Finanzberichte am Dienstag, den 20. August 2024, vor der Eröffnung der US-Märkte veröffentlichen.
Eine Telefonkonferenz und ein Webcast sind für 10:00 Uhr EDT am selben Tag geplant. Investoren können je nach Standort über verschiedene Einwahlnummern teilnehmen. Ein Live-Webcast wird außerdem im Nur-Zuhören-Modus verfügbar sein. Um den Prozess zu vereinfachen, bietet CollPlant eine Call me™-Funktion für einen einfachen Zugang an. Investoren können Fragen im Voraus per E-Mail an Dan Ferry von LifeSci Advisors stellen.
- None.
- None.
Conference call to be held on Tuesday, August 20, 2024, at 10:00 a.m.
REHOVOT,
Conference call information
To participate in the conference call, please use the dial-in information below:
U.S. investors: 1-877-407-9716
Investors outside of the
Conference ID: 13746304
Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:
https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6
Webcast information
A live webcast will also be available in listen-only mode and can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.
Submit questions to management in advance of the call
To ask management a question ahead of the call, please email Dan Ferry at LifeSci Advisors LLC up until 24 hours before the event at daniel@lifesciadvisors.com.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com.
Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
Contacts:
CollPlant:
Eran Rotem
Deputy CEO & CFO
+972-73-2325600
eran@collplant.com
Investors:
LifeSci Advisors
Dan Ferry
daniel@lifesciadvisors.com
View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-2024-second-quarter-financial-statements-and-conference-call-information-302215375.html
SOURCE CollPlant
FAQ
When will CollPlant Biotechnologies (CLGN) release its Q2 2024 financial results?
What time is CollPlant's Q2 2024 earnings conference call scheduled for?
How can investors participate in CollPlant's Q2 2024 earnings call?
Will there be a webcast for CollPlant's Q2 2024 earnings call?
How can investors submit questions for CollPlant's Q2 2024 earnings call?
